• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

碱基配对RNA中β-羟基胞苷的互变异构状态。

The Tautomeric State of -Hydroxycytidine within Base-Paired RNA.

作者信息

Bessi Irene, Stiller Carina, Schroeder Till, Schäd Benedikt, Grüne Matthias, Dietzsch Julia, Höbartner Claudia

机构信息

Institute of Organic Chemistry, Julius-Maximilians-University Würzburg, Am Hubland, 97074 Würzburg, Bavaria, Germany.

Center for Nanosystems Chemistry, Julius-Maximilians-University Würzburg, 97074 Würzburg, Bavaria, Germany.

出版信息

ACS Cent Sci. 2024 Apr 25;10(5):1084-1093. doi: 10.1021/acscentsci.4c00146. eCollection 2024 May 22.

DOI:10.1021/acscentsci.4c00146
PMID:38799674
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11117714/
Abstract

Antiviral nucleoside analogues (e.g., Molnupiravir, Remdesivir) played key roles in the treatment of COVID-19 by targeting SARS-CoV-2 RNA-dependent RNA polymerase (RdRp). The nucleoside of Molnupiravir, -hydroxycytidine (NHC), exists in two tautomeric forms that pair either with G or A within the RdRp active site, causing an accumulation of viral RNA mutations during replication. Detailed insights into the tautomeric states within base pairs and the structural influence of NHC in RNA are still missing. In this study, we investigate the properties of NHC:G and NHC:A base pairs in a self-complementary RNA duplex by UV thermal melting and NMR spectroscopy using atom-specifically N-labeled versions of NHC that were incorporated into oligonucleotides by solid-phase synthesis. NMR analysis revealed that NHC forms a Watson-Crick base pair with G via its amino form, whereas two equally populated conformations were detected for the NHC:A base pair: a weakly hydrogen-bonded Watson-Crick base pair with NHC in the imino form and another conformation with A shifted toward the minor groove. Moreover, we found a variable influence of NHC:G and NHC:A base pairs on the neighboring duplex environment. This study provides conclusive experimental evidence for the existence of two tautomeric forms of NHC within RNA base pairs.

摘要

抗病毒核苷类似物(如莫努匹拉韦、瑞德西韦)通过靶向严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的RNA依赖性RNA聚合酶(RdRp)在治疗2019冠状病毒病(COVID-19)中发挥了关键作用。莫努匹拉韦的核苷β-D-羟基胞苷(NHC)以两种互变异构形式存在,它们在RdRp活性位点内与鸟嘌呤(G)或腺嘌呤(A)配对,导致病毒RNA在复制过程中发生突变积累。目前仍缺乏对碱基对内互变异构状态以及NHC在RNA中的结构影响的详细了解。在本研究中,我们通过紫外热变性和核磁共振光谱研究了自互补RNA双链体中NHC:G和NHC:A碱基对的性质,使用通过固相合成掺入寡核苷酸中的原子特异性N标记的NHC版本。核磁共振分析表明,NHC通过其氨基形式与G形成沃森-克里克碱基对,而对于NHC:A碱基对检测到两种同样丰富的构象:一种是NHC以亚氨基形式存在的弱氢键沃森-克里克碱基对,另一种构象是A向小沟移动。此外,我们发现NHC:G和NHC:A碱基对对相邻双链体环境有可变影响。本研究为RNA碱基对内NHC的两种互变异构形式的存在提供了确凿的实验证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/886d/11117714/fa93ba0301dc/oc4c00146_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/886d/11117714/b4d8a9a81a20/oc4c00146_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/886d/11117714/c151a2353a1d/oc4c00146_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/886d/11117714/68b14dfce92d/oc4c00146_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/886d/11117714/090d09c3a4de/oc4c00146_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/886d/11117714/19966dcca83f/oc4c00146_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/886d/11117714/fa93ba0301dc/oc4c00146_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/886d/11117714/b4d8a9a81a20/oc4c00146_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/886d/11117714/c151a2353a1d/oc4c00146_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/886d/11117714/68b14dfce92d/oc4c00146_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/886d/11117714/090d09c3a4de/oc4c00146_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/886d/11117714/19966dcca83f/oc4c00146_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/886d/11117714/fa93ba0301dc/oc4c00146_0006.jpg

相似文献

1
The Tautomeric State of -Hydroxycytidine within Base-Paired RNA.碱基配对RNA中β-羟基胞苷的互变异构状态。
ACS Cent Sci. 2024 Apr 25;10(5):1084-1093. doi: 10.1021/acscentsci.4c00146. eCollection 2024 May 22.
2
Binding Mechanism of the Active Form of Molnupiravir to RdRp of SARS-CoV-2 and Designing Potential Analogues: Insights from Molecular Dynamics Simulations.莫努匹拉韦活性形式与新型冠状病毒核糖核酸聚合酶的结合机制及潜在类似物设计:分子动力学模拟的见解
ACS Omega. 2024 Sep 24;9(40):41583-41598. doi: 10.1021/acsomega.4c05469. eCollection 2024 Oct 8.
3
Direct NMR Evidence that Transient Tautomeric and Anionic States in dG·dT Form Watson-Crick-like Base Pairs.直接 NMR 证据表明 dG·dT 中瞬时互变异构和阴离子态形成 Watson-Crick 样碱基对。
J Am Chem Soc. 2017 Mar 29;139(12):4326-4329. doi: 10.1021/jacs.7b01156. Epub 2017 Mar 20.
4
Molnupiravir promotes SARS-CoV-2 mutagenesis via the RNA template.莫努匹韦通过 RNA 模板促进 SARS-CoV-2 突变。
J Biol Chem. 2021 Jul;297(1):100770. doi: 10.1016/j.jbc.2021.100770. Epub 2021 May 11.
5
SARS-CoV-2 RdRp uses NDPs as a substrate and is able to incorporate NHC into RNA from diphosphate form molnupiravir.SARS-CoV-2 RdRp 以 NDPs 为底物,能够将 NHC 从二磷酸形式的 molnupiravir 掺入 RNA 中。
Int J Biol Macromol. 2023 Jan 31;226:946-955. doi: 10.1016/j.ijbiomac.2022.12.112. Epub 2022 Dec 14.
6
Synthesis and anti-SARS-CoV-2 evaluation of lipid prodrugs of β-D-N-hydroxycytidine (NHC) and a 3'-fluoro-substituted analogue of NHC.β-D-N-羟基胞苷(NHC)及其 3'-氟取代类似物的脂质前药的合成及抗 SARS-CoV-2 活性评价。
Bioorg Chem. 2023 Jun;135:106527. doi: 10.1016/j.bioorg.2023.106527. Epub 2023 Apr 6.
7
Evaluation of N4-hydroxycytidine incorporation into nucleic acids of SARS-CoV-2-infected host cells by direct measurement with liquid chromatography-mass spectrometry.采用液相色谱-质谱联用技术直接检测 SARS-CoV-2 感染宿主细胞核酸中 N4-羟胞苷的掺入。
Nucleosides Nucleotides Nucleic Acids. 2024;43(8):813-821. doi: 10.1080/15257770.2024.2346550. Epub 2024 May 13.
8
Molnupiravir: Mechanism of action, clinical, and translational science.莫努匹韦:作用机制、临床和转化科学。
Clin Transl Sci. 2024 Feb;17(2):e13732. doi: 10.1111/cts.13732.
9
Assessing the mitochondrial safety profile of the molnupiravir active metabolite, β-d-N4-hydroxycytidine (NHC), in the physiologically relevant HepaRG model.在生理相关的HepaRG模型中评估莫努匹拉韦活性代谢物β-d-N4-羟基胞苷(NHC)的线粒体安全性。
Toxicol Res (Camb). 2024 Feb 7;13(1):tfae012. doi: 10.1093/toxres/tfae012. eCollection 2024 Feb.
10
Isostericity and tautomerism of base pairs in nucleic acids.碱基对在核酸中的等排性和互变异构现象。
FEBS Lett. 2014 Aug 1;588(15):2464-9. doi: 10.1016/j.febslet.2014.06.031. Epub 2014 Jun 17.

本文引用的文献

1
Thermodynamic and Kinetic Characteristics of Molnupiravir Tautomers and Its Complexes with RNA Purine Bases as an Explanation of the Possible Mechanism of Action of This Novel Antiviral Medicine: A Quantum-Chemical Study.莫努匹拉韦互变异构体及其与RNA嘌呤碱基复合物的热力学和动力学特征,以解释这种新型抗病毒药物可能的作用机制:一项量子化学研究
J Org Chem. 2023 Oct 6;88(19):14048-14064. doi: 10.1021/acs.joc.3c01580. Epub 2023 Sep 27.
2
A molnupiravir-associated mutational signature in global SARS-CoV-2 genomes.全球 SARS-CoV-2 基因组中与莫努匹韦相关的突变特征。
Nature. 2023 Nov;623(7987):594-600. doi: 10.1038/s41586-023-06649-6. Epub 2023 Sep 25.
3
N4-hydroxycytidine, the active compound of Molnupiravir, promotes SARS-CoV-2 mutagenesis and escape from a neutralizing nanobody.
N4-羟基胞苷是莫努匹韦的活性成分,可促进严重急性呼吸综合征冠状病毒2(SARS-CoV-2)发生突变并逃避一种中和纳米抗体。
iScience. 2023 Aug 30;26(10):107786. doi: 10.1016/j.isci.2023.107786. eCollection 2023 Oct 20.
4
A Protonated Cytidine Stabilizes the Ligand-Binding Pocket in the PreQ Riboswitch in Thermophilic Bacteria.质子化胞嘧啶稳定嗜热菌前体 Q 盒中的配体结合口袋。
Chembiochem. 2023 Aug 1;24(15):e202300228. doi: 10.1002/cbic.202300228. Epub 2023 Jun 28.
5
Therapeutic strategies for COVID-19: progress and lessons learned.COVID-19 的治疗策略:进展与经验教训。
Nat Rev Drug Discov. 2023 Jun;22(6):449-475. doi: 10.1038/s41573-023-00672-y. Epub 2023 Apr 19.
6
Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial.莫努匹韦联合常规治疗与单纯常规治疗用于 COVID-19 高风险不良结局成人患者早期治疗的比较(PANORAMIC):一项开放标签、平台适应性随机对照试验。
Lancet. 2023 Jan 28;401(10373):281-293. doi: 10.1016/S0140-6736(22)02597-1. Epub 2022 Dec 22.
7
Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients.莫努匹韦片用于非住院 COVID-19 患者的口服治疗。
N Engl J Med. 2022 Feb 10;386(6):509-520. doi: 10.1056/NEJMoa2116044. Epub 2021 Dec 16.
8
Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis.莫努匹拉韦诱导的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)诱变机制。
Nat Struct Mol Biol. 2021 Sep;28(9):740-746. doi: 10.1038/s41594-021-00651-0. Epub 2021 Aug 11.
9
Molnupiravir promotes SARS-CoV-2 mutagenesis via the RNA template.莫努匹韦通过 RNA 模板促进 SARS-CoV-2 突变。
J Biol Chem. 2021 Jul;297(1):100770. doi: 10.1016/j.jbc.2021.100770. Epub 2021 May 11.
10
β-d-N4-hydroxycytidine Inhibits SARS-CoV-2 Through Lethal Mutagenesis But Is Also Mutagenic To Mammalian Cells.β-d-N4-羟基胞苷通过致命诱变抑制 SARS-CoV-2,但对哺乳动物细胞也具有诱变作用。
J Infect Dis. 2021 Aug 2;224(3):415-419. doi: 10.1093/infdis/jiab247.